Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Genetic causes of chorea
- CAG repeat diseases
- Huntington’s disease (1)
- Huntington’s disease (2)
- HD is caused by CAG repeat expansion in HTT
- HD genetics - CAG repeat threshold and HD
- HD CAG repeat length frequencies
- Genetic anticipation in HD
- Repeat length predicts age of onset
- Paternal transmission: CAG increase
- Pathobiology of HD
- The HD mutation and huntingtin protein
- Huntingtin and the molecular pathogenesis of HD
- Clinical features of HD
- HD is not just a disease of the basal ganglia
- HD is more than a disease of the brain
- Onset and early disease in HD
- Subclinical chorea
- Mid-course adult-onset HD
- Ballistic chorea
- Juvenile HD with onset less than 20y
- Elderly onset HD – over 75 years of age
- Advanced stage HD
- Psychiatric/behavioural
- Cognitive phenotype
- Genetic testing
- Predictive genetic testing for HD
- Genetic HD-like disorders
- Conditions less likely to mimic HD
- HDL2
- Genetics of HDL2
- Epidemiology and pathology of HDL2
- Spinocerebellar ataxia 17
- Genetics of SCA17
- T2-weighted axial brain MRI in SCA17
- Neuroferritinopathy
- Clinical features of neuroferritinopathy
- Genetics of neuroferritinopathy
- Neuroferritinopathy: investigations & pathology
- T2* MRI in neuroferritinopathy
- Neuroacanthocytosis
- Chorea-acanthocytosis
- Chorea-acanthocytosis - clinical features
- McLeod syndrome
- McLeod syndrome - clinical features
- Benign hereditary chorea
- Prion diseases
- PKAN (PANK2 mutation)
- C9orf72 (1)
- C9orf72 (2)
- C9orf72 (3)
- Phenotypic heterogeneity of C9orf72
- HD mimics (phenocopies)
- Genetic HD mimics
- HD research website
- HD Buzz
- Huntington’s disease: reading
- Acknowledgements
Topics Covered
- Huntington’s disease
- Huntington’s disease like disorders
- Chorea
- Anticipation
- Pathobiology of Huntington’s disease
- Huntingtin protein misfolding
- Aggregation
- Ubiquitous expression including in peripheral tissues -Juvenile Huntington’s disease/Westphal variant
- Psychiatric, behavioural and cognitive symptomatology
- HD phenocopies
- C9Orf72 and SCA17
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Tabrizi, S. (2014, July 1). Huntington’s disease and HD-like disorders [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/MLKL4690.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Sarah Tabrizi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
"Huntington's Disease
and HD-like Disorders."
Sarah Tabrizi, professor of
neurology at the Institute
of Neurology, University
College London.
0:11
Genetic causes of chorea:
HD and HD-like disorders.
HD-like disorders can be
called HD phenocopies.
They're all characterized by
variable presentation of chorea,
dystonia, and parkinsonism,
cognitive impairment,
and psychiatric disturbance.
0:31
The CAG repeat diseases
comprise Huntington's disease,
DRPLA, SBMA, and SCA1,
2, 3, 6, 7 and 17.
They're sometimes called
the PolyQ disorders.
0:48
Huntington's disease.
0:52
This was first described by
George Huntington in 1872.
It is the commonest
genetic cause of chorea.
It is dominantly inherited.
And the mean age of
onset is about 40.
About 8% of new cases
have no family history.
1:11
Huntington's disease is caused
by a CAG repeat expansion
in the Huntington gene encoding
the Huntington protein.
It was cloned in 1993 by a large
collaborative research group.
1:26
HD genetics are interesting.
And there is a CAG repeat threshold.
Normal individuals have
less than 29 CAG repeats.
And this is not pathogenic,
and it's not unstable.
Between 29 and 35, it's an
intermediate repeat range.
It's not pathogenic
to that individual,
but it may expand into disease
range in future generations
and appear like a new mutation.
This is because of paternal meiotic
instability during spermatogenesis
where CAG repeat
expansions can occur
during spermatogenesis due
to meiotic instability.
This means that in
future generations,
the expansion can be pathogenic.
There is a reduced penetrance range
of 36 to 39 CAG repeats, which
can be pathogenic and has a risk
of HD of between 25% at 36 repeats
and 90% at 39 repeats.
However, if you have
40 or more CAG repeats,
that is fully pathogenic
and fully penetrant
and always causes
Huntington's disease.